Francis Burrows sold $225k of KURA
Chief Scientific Officer at Kura Oncology, Inc.. 20,726 shares at an average of $10.83, traded Sep 24, 2026, filed Sep 25, 2026.
Score components
- +15RoleOfficer
- +12Trade size$225k at market
- +10Share of holdings soldSold 33% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-402815, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | MOption exercise Common Stock | +30,000 | $6.15 | $185k | 63,053 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock | -20,726 | $10.83 | $225k | 42,327 | 17 d ago |
| Sep 24, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 0 | 17 d ago |
Related signals
Other insiders at Kura Oncology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 19Weak | Kura Oncology, Inc. | Teresa Brophy Bair Chief Legal Officer | $89k 8,442 shares | -4% | |
| 37Weak | Kura Oncology, Inc. | Thomas James Doyle SVP, Finance & Accounting | $48k 4,607 shares | -3% | |
| 25Weak | Kura Oncology, Inc. | Kathleen Ford Chief Operating Officer | $112k 10,574 shares | -7% | |
| 30Weak | Kura Oncology, Inc. | Brian T. Powl Chief Commercial Officer | $345k 32,450 shares | -19% | |
| 32Weak | Kura Oncology, Inc. | Mollie Leoni Chief Medical Officer | $440k 41,250 shares | -23% | |
| 0Weak | Kura Oncology, Inc. | Teresa Brophy Bair Chief Legal Officer | $21k 2,256 shares | -1% | |
| 40Moderate | Kura Oncology, Inc. | Teresa Brophy Bair Chief Legal Officer | $95k 11,208 shares | -5% | |
| 30Weak | Kura Oncology, Inc. | Francis Burrows Chief Scientific Officer | $11k 1,311 shares | -4% | |
| 37Weak | Kura Oncology, Inc. | Thomas James Doyle SVP, Finance & Accounting | $60k 7,142 shares | -5% | |
| 35Weak | Kura Oncology, Inc. | Kathleen Ford Chief Operating Officer | $15k 1,813 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.